相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Single-Dose Liposomal Amphotericin B Treatment for Cryptococcal Meningitis
J. N. Jarvis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Antifungal Susceptibility Does Not Correlate With Fungal Clearance or Survival in AIDS-Associated Cryptococcal Meningitis
Lucy O'Connor et al.
CLINICAL INFECTIOUS DISEASES (2021)
The Antifungal Pipeline: Fosmanogepix, Ibrexafungerp, Olorofim, Opelconazole, and Rezafungin
Martin Hoenigl et al.
DRUGS (2021)
Fungal-Selective Resorcylate Aminopyrazole Hsp90 Inhibitors: Optimization of Whole-Cell Anticryptococcal Activity and Insights into the Structural Origins of Cryptococcal Selectivity
Paul T. Marcyk et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Consensus guidelines for the diagnosis and management of cryptococcosis and rare yeast infections in the haematology/oncology setting, 2021
Christina C. Chang et al.
INTERNAL MEDICINE JOURNAL (2021)
An open label randomized controlled trial of tamoxifen combined with amphotericin B and fluconazole for cryptococcal meningitis
Nguyen Thi Thuy Ngan et al.
ELIFE (2021)
Identification of Off-Patent Drugs That Show Synergism with Amphotericin B or That Present Antifungal Action against Cryptococcus neoformans and Candida spp.
Suelen Andreia Rossi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
The state of latency in microbial pathogenesis
Liise-anne Pirofski et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Short-course High-dose Liposomal Amphotericin B for Human Immunodeficiency Virus-associated Cryptococcal Meningitis: A Phase 2 Randomized Controlled Trial
Joseph N. Jarvis et al.
CLINICAL INFECTIOUS DISEASES (2019)
APX001 Pharmacokinetic/Pharmacodynamic Target Determination against Aspergillus fumigatus in an In Vivo Model of Invasive Pulmonary Aspergillosis
Miao Zhao et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Three phylogenetic groups have driven the recent population expansion of Cryptococcus neoformans
P. M. Ashton et al.
NATURE COMMUNICATIONS (2019)
The combination of tamoxifen with amphotericin B, but not with fluconazole, has synergistic activity against the majority of clinical isolates of Cryptococcus neoformans
Trieu Phan Hai et al.
MYCOSES (2019)
Prospective Trial of Cerebrospinal Fluid Filtration After Aneurysmal Subarachnoid Hemorrhage via Lumbar Catheter (PILLAR)
Spiros L. Blackburn et al.
STROKE (2019)
Adjunctive sertraline for HIV-associated cryptococcal meningitis: a randomised, placebo-controlled, double-blind phase 3 trial
Joshua Rhein et al.
LANCET INFECTIOUS DISEASES (2019)
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012-2016
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2019)
Mortality in hospitalized patients with tuberculous meningitis
Jaime Soria et al.
BMC INFECTIOUS DISEASES (2019)
Clinical evaluation of the antifungal effect of sertraline in the treatment of cryptococcal meningitis in HIV patients: a single Mexican center experience
Hiram Villanueva-Lozano et al.
INFECTION (2018)
Fungal-specific Cyp51 inhibitor VT-1598 demonstrates in vitro activity against Candida and Cryptococcus species, endemic fungi, including Coccidioides species, Aspergillus species and Rhizopus arrhizus
Nathan P. Wiederhold et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
Miltefosine Has a Postantifungal Effect and Induces Apoptosis in Cryptococcus Yeasts
Cristina de Castro Spadari et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
In vitro and in vivo Evaluation of APX001A/APX001 and other Gwt1 inhibitors against Cryptococcus
Karen Joy Shaw et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Repurposing and Reformulation of the Antiparasitic Agent Flubendazole for Treatment of Cryptococcal Meningoencephalitis, a Neglected Fungal Disease
Gemma L. Nixon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Novel Treatment of Cryptococcal Meningitis via Neurapheresis Therapy
Gordon J. Smilnak et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
Antifungal Combinations for Treatment of Cryptococcal Meningitis in Africa
S. F. Molloy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
High Cryptococcal Antigen Titers in Blood Are Predictive of Subclinical Cryptococcal Meningitis Among Human Immunodeficiency Virus-Infected Patients
Rachel M. Wake et al.
CLINICAL INFECTIOUS DISEASES (2018)
Disseminated Cryptococcosis with Adrenal Insufficiency and Meningitis in an Immunocompetent Individual
Misa Ito et al.
INTERNAL MEDICINE (2017)
Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis
Radha Rajasingham et al.
LANCET INFECTIOUS DISEASES (2017)
Comparative genomics of Cryptococcus neoformans var. grubii associated with meningitis in HIV infected and uninfected patients in Vietnam
Jeremy N. Day et al.
PLOS NEGLECTED TROPICAL DISEASES (2017)
The Case for Adopting the Species Complex Nomenclature for the Etiologic Agents of Cryptococcosis
Kyung J. Kwon-Chung et al.
MSPHERE (2017)
Inadequacy of High-Dose Fluconazole Monotherapy Among Cerebrospinal Fluid Cryptococcal Antigen (CrAg)-Positive Human Immunodeficiency Virus-Infected Persons in an Ethiopian CrAg Screening Program
Tafese Beyene et al.
CLINICAL INFECTIOUS DISEASES (2017)
Comparison of clinical features and prognostic factors in HIV-negative adults with cryptococcal meningitis and tuberculous meningitis: a retrospective study
Junyan Qu et al.
BMC INFECTIOUS DISEASES (2017)
Activity of sertraline against Cryptococcus neoformans: in vitro and in vivo assays
Rogelio de J. Trevino-Rangel et al.
MEDICAL MYCOLOGY (2016)
The Investigational Drug VT-1129 Is a Highly Potent Inhibitor of Cryptococcus Species CYP51 but Only Weakly Inhibits the Human Enzyme
Andrew G. S. Warrilow et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Cryptococcal Meningitis Treatment Strategies Affected by the Explosive Cost of Flucytosine in the United States: A Cost-effectiveness Analysis
Matthew Merry et al.
CLINICAL INFECTIOUS DISEASES (2016)
Cryptococcosis
Eileen K. Maziarz et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2016)
Efficacy of adjunctive sertraline for the treatment of HIV-associated cryptococcal meningitis: an open-label dose-ranging study
Joshua Rhein et al.
LANCET INFECTIOUS DISEASES (2016)
Inhibition of heat-shock protein 90 enhances the susceptibility to antifungals and reduces the virulence of Cryptococcus neoformans/Cryptococcus gattii species complex
Rossana de Aguiar Cordeiro et al.
MICROBIOLOGY-SGM (2016)
Adjunctive Dexamethasone in HIV-Associated Cryptococcal Meningitis
J. Beardsley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Validation of a severity grading score (SGS) system for predicting the course of disease and mortality in patients with Crimean-Congo hemorrhagic fever (CCHF)
M. Bakir et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2015)
Cryptococcal Meningitis with Multiple Cranial Nerves Palsies: A Review of Literature
Adhiti Krishnamoorthy et al.
JOURNAL OF GLOBAL INFECTIOUS DISEASES (2015)
Timing of Antiretroviral Therapy after Diagnosis of Cryptococcal Meningitis
David R. Boulware et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Estrogen Receptor Antagonists Are Anti-Cryptococcal Agents That Directly Bind EF Hand Proteins and Synergize with Fluconazole In Vivo
Arielle Butts et al.
MBIO (2014)
Cryptococcus neoformans and Cryptococcus gattii, the Etiologic Agents of Cryptococcosis
Kyung J. Kwon-Chung et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2014)
Early Versus Delayed Antiretroviral Therapy and Cerebrospinal Fluid Fungal Clearance in Adults With HIV and Cryptococcal Meningitis
Gregory P. Bisson et al.
CLINICAL INFECTIOUS DISEASES (2013)
Pharmacodynamics of Liposomal Amphotericin B and Flucytosine for Cryptococcal Meningoencephalitis: Safe and Effective Regimens for Immunocompromised Patients
Lucy O'Connor et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Combination Antifungal Therapy for Cryptococcal Meningitis
Jeremy N. Day et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Cryptococcus gattii Induces a Cytokine Pattern That Is Distinct from Other Cryptococcal Species
Teske Schoffelen et al.
PLOS ONE (2013)
Population Pharmacokinetics of Conventional and Intermittent Dosing of Liposomal Amphotericin B in Adults: a First Critical Step for Rational Design of Innovative Regimens
William W. Hope et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
The Antidepressant Sertraline Provides a Promising Therapeutic Option for Neurotropic Cryptococcal Infections
Bing Zhai et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Comparison of the Early Fungicidal Activity of High-Dose Fluconazole, Voriconazole, and Flucytosine as Second-Line Drugs Given in Combination With Amphotericin B for the Treatment of HIV-Associated Cryptococcal Meningitis
Angela Loyse et al.
CLINICAL INFECTIOUS DISEASES (2012)
Ocular cryptococcosis as a presenting manifestation of cryptococcal meningitis in a patient with HIV
S-M Chai et al.
INTERNATIONAL JOURNAL OF STD & AIDS (2012)
Disseminated cryptococcosis presenting with generalized lymphadenopathy
Kandathil Joseph Philip et al.
JOURNAL OF CYTOLOGY (2012)
Use of Terbinafine in the Treatment Protocol of Intestinal Cryptococcus neoformans in a Dog
Gavin L. Olsen et al.
JOURNAL OF THE AMERICAN ANIMAL HOSPITAL ASSOCIATION (2012)
Terbinafine inhibits Cryptococcus neoformans growth and modulates fungal morphology
Caroline Rezende Guerra et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2012)
Early Clinical and Subclinical Visual Evoked Potential and Humphrey's Visual Field Defects in Cryptococcal Meningitis
Anand Moodley et al.
PLOS ONE (2012)
Most Cases of Cryptococcal Meningitis in HIV-Uninfected Patients in Vietnam Are Due to a Distinct Amplified Fragment Length Polymorphism-Defined Cluster of Cryptococcus neoformans var. grubii VN1
Jeremy N. Day et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2011)
Cross-species discovery of syncretic drug combinations that potentiate the antifungal fluconazole
Michaela Spitzer et al.
MOLECULAR SYSTEMS BIOLOGY (2011)
Cryptococcus gattii: a resurgent fungal pathogen
Vishnu Chaturvedi et al.
TRENDS IN MICROBIOLOGY (2011)
The Outbreak of Cryptococcus gattii in Western North America: Epidemiology and Clinical Issues
Edmond J. Byrnes et al.
Current Infectious Disease Reports (2011)
A prospective descriptive study of cryptococcal meningitis in HIV uninfected patients in Vietnam - high prevalence of Cryptococcus neoformans var grubii in the absence of underlying disease
Tran T. H. Chau et al.
BMC INFECTIOUS DISEASES (2010)
Comparison of 2 Doses of Liposomal Amphotericin B and Conventional Amphotericin B Deoxycholate for Treatment of AIDS-Associated Acute Cryptococcal Meningitis: A Randomized, Double-Blind Clinical Trial of Efficacy and Safety
Richard J. Hamill et al.
CLINICAL INFECTIOUS DISEASES (2010)
Early versus Delayed Initiation of Antiretroviral Therapy for Concurrent HIV Infection and Cryptococcal Meningitis in Sub-Saharan Africa
Azure T. Makadzange et al.
CLINICAL INFECTIOUS DISEASES (2010)
Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America
John R. Perfect et al.
CLINICAL INFECTIOUS DISEASES (2010)
Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS
Benjamin J. Park et al.
AIDS (2009)
Cryptococcosis of the Upper Genital Tract
Manish Gopal et al.
AIDS PATIENT CARE AND STDS (2009)
Antifungal Activity of Tamoxifen: In Vitro and In Vivo Activities and Mechanistic Characterization
Kristy Dolan et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
A safety and feasibility study comparing an intermittent high dose with a daily standard dose of liposomal amphotericin B for persistent neutropenic fever
Michael Ellis et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2009)
Major Role for Amphotericin B-Flucytosine Combination in Severe Cryptococcosis
Francoise Dromer et al.
PLOS ONE (2008)
Hexadecylphosphocholine (Miltefosine) has broad-spectrum fungicidal activity and is efficacious in a mouse model of cryptococcosis
F Widmer et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Evaluation of Mycograb((R)), amphotericin B, caspofungin, and fluconazole in combination against Cryptococcus neoformans by checkerboard and time-kill methodologies
L Nooney et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2005)
A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada)
SE Kidd et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial
AE Brouwer et al.
LANCET (2004)
In vitro interaction of flucytosine with conventional and new antifungals against Cryptococcus neoformans clinical isolates
P Schwarz et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Preclinical assessment of the efficacy of mycograb, a human recombinant antibody against fungal HSP90
RC Matthews et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy
PG Pappas et al.
CLINICAL INFECTIOUS DISEASES (2001)
Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis
JR Graybill et al.
CLINICAL INFECTIOUS DISEASES (2000)
分享论文
